Scrip M&A Podcast: US FTC Review of Mergers and Acquisitions
Citeline Podcasts
English - October 02, 2023 16:04 - 37 minutes - 15.6 MB - ★★★★★ - 24 ratingsBusiness News Business News Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Drug Fix: Adcomm Rejects NurOwn For ALS, FDA In Shutdown Mode, Limited Price Negotiation Savings
Next Episode: Scrip’s Five Must-Know Things – 3 October 2023
Scrip writers Joseph Haas and Jessica Merrill discuss US FTC overview of biopharma mergers like Amgen/Horizon and Pfizer/Seagen with Leerink Partners' analyst Dan Lepanto and ZS Associates partner Cody Powers.